Aushon BioSystems Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Aushon BioSystems Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011805
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aushon BioSystems Inc (Aushon) is a medical device provider that offers biomarker measurement and analysis products. The company provides biomarker therapeutic areas in microarray printing technology. Its products include ciraplex assay, cirascan imaging and cirasoft analysis and cira services. Aushon offers services such as ciraplex ULTRA ultrasensitive assay, cirascan immunoassay system, cira services sample testing service and arrayer. The center products provides drug discovery, pre-clinical development, clinical trials, personalized medicine and companion diagnostics solutions. Its products serve in the field of oncology; inflammatory diseases; neurodegenerative diseases; cardiovascular disease and diabetes and obesity. The center caters to pharmaceutical, biotechnology, academic and diagnostic industries. Aushon is headquartered in Billerica, Massachusetts, the US.

Aushon BioSystems Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aushon BioSystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aushon BioSystems Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aushon BioSystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aushon BioSystems Inc, Medical Devices Deals, 2011 to YTD 2017 8
Aushon BioSystems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aushon BioSystems Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Aushon BioSystems Raises Additional USD3 Million in Venture Financing 10
Aushon BioSystems Raises USD3.6 Million in Financing Round 11
Aushon BioSystems Raises USD8 million in Venture Financing 12
Aushon BioSystems Raises US$5.5 Million In Venture Financing 13
Aushon BioSystems Inc – Key Competitors 14
Aushon BioSystems Inc – Key Employees 15
Aushon BioSystems Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
May 17, 2017: Stanley N. Lapidus Joins Aushon BioSystem’s Board of Directors 17
Other Significant Developments 18
Sep 26, 2017: Aushon BioSystems and ABL Announce Adoption of the Cira Platform for Multiplex and Ultrasensitive Biomarker Testing 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Aushon BioSystems Inc, Pharmaceuticals & Healthcare, Key Facts 2
Aushon BioSystems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Aushon BioSystems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aushon BioSystems Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aushon BioSystems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aushon BioSystems Inc, Medical Devices Deals, 2011 to YTD 2017 8
Aushon BioSystems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Aushon BioSystems Raises Additional USD3 Million in Venture Financing 10
Aushon BioSystems Raises USD3.6 Million in Financing Round 11
Aushon BioSystems Raises USD8 million in Venture Financing 12
Aushon BioSystems Raises US$5.5 Million In Venture Financing 13
Aushon BioSystems Inc, Key Competitors 14
Aushon BioSystems Inc, Key Employees 15

★海外企業調査レポート[Aushon BioSystems Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sizzling Pub Co.:企業の戦略・SWOT・財務分析
    SummarySizzling Pub Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findin …
  • Aspect Imaging Inc:企業のM&A・提携動向(医療機器分野)
    Summary Aspect Imaging Inc (Aspect Imaging) is a medical device company that develops and manufactures magnetic resonance imaging systems. The company’s products include wrist MRI systems, nanoscan, 3D MR-based histology system, contrast agents, real-time rheology system and compact nuclear magnetic …
  • Orthopaedic Synergy Incorporated:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Orthopaedic Synergy Incorporate …
  • New Standard Energy Limited (NSE):企業の財務及び戦略的SWOT分析
    Summary New Standard Energy Limited (NSE) is an oil and gas exploration company that produces, develops and explores oil and gas. The company has onshore oil and gas exploration assets in the Canning Basin in the north-west of Western Australia. NSE undertakes projects such as Eagle Ford acreage is …
  • Double Coin Holdings Ltd.の企業概要及び財務/SWOT分析
    Double Coin Holdings Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quart …
  • OK Biotech Co. Ltd. (4155):企業のM&A・提携動向(医療機器分野)
    Summary OK Biotech Co. Ltd. (OK Biotech) is a medical device company that manufactures and markets blood glucose monitoring devices and other related homecare medical products. The company’s products include portable nebulizer, blood glucose meter, glucometer, blood sugar meter and blood glucose tes …
  • Syntopix Group plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Syntopix Group plc Mergers and …
  • Petrel Resources Plc (PET)(石油・ガス分野):企業M&A動向
    Summary Petrel Resources Plc (Petrel Resources) is an oil and gas exploration and production company. The company carries out exploration of crude oil and natural gas in Iraq. Its areas of operations include Subba and Luhais in Southern Iraq, Tano Basin in Ghana, and Porcupine Basin in Ireland. Petr …
  • Comair Ltd.の企業概要及び財務/SWOT分析
    Comair Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts …
  • ELITechGroup Inc-医療機器分野:企業M&A・提携分析
    Summary ELITechGroup Inc (ELITech) is a medical device company that manufactures and distributes in vitro diagnostic equipment and reagents. The company’s products portfolio includes clinical chemistry, cytology, hematology, immunology, microbiology and molecular diagnostics. Its clinical chemistry …
  • The Armstrong Bros. Tool Co.:企業の戦略的SWOT分析
    The Armstrong Bros. Tool Co. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Evolving Systems, Inc. (EVOL):企業財務及び戦略的SWOT分析
    Summary Evolving Systems, Inc. (Evolving Systems) is a technology company that provides development, delivering and supporting technology and vendor independent software solutions. The company offers software solutions such as real-time lifecycle marketing, dynamic sim allocation, tertio service act …
  • LFB SA:企業のM&A・提携動向(医療分野)
    Summary LFB SA (LFB), a subsidiary of Ministry of Health France is a biopharmaceutical company that manufactures and markets medicinal products. The company offers immunology, haemostasis, perinatal and intensive care and adverse effect reporting products. Its services comprise bio production and te …
  • Dai Ichi Karkaria Ltd (526821):企業の財務及び戦略的SWOT分析
    Summary Dai Ichi Karkaria Ltd (DKL) is a chemical company that manufactures and markets specialty chemicals. The company offers products such as acid corrosion inhibitors, acid thickener, additives for rayon, afterwaxing agent, anticreasing agent, antifrothing agent, antistatic agent, bactericide, c …
  • Rheonix, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Rheonix, Inc. Mergers and Acqui …
  • Sears Holdings Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Sears Holdings Corporation Merg …
  • Agilysys, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Agilysys, Inc. Mergers and Acqu …
  • CAS Medical Systems, Inc. (CASM):企業概要、財務及び戦略的SWOT分析
    Summary CAS Medical Systems, Inc. (CASMED) is a medical technology company. The company designs, manufactures and markets technologies and monitors. Its products include FORE-SIGHT absolute tissue oximeter, blood pressure measurement technology, vital signs monitors and supplies for neonatal intensi …
  • Bio-Techne (TECH):(医療機器分野)企業M&A及び提携動向
    Summary Bio-Techne is a holding company. The company develops, produces and sells biotechnology products and hematology products. It operates through its two business divisions including hematology division and biotechnology division. Bio-Techne’s hematology division develops and manufactures hemato …
  • Altor BioScience Corp.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Altor BioScience Corp. Mergers …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆